Bertrand William C JR
Insider CIK 1291937 · SLXP See Remarks · INFI General Counsel · ARDX Director · ADAP Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARDX ARDELYX, INC. | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2026-06-16 | 2026-06-18 | 12,345 | — | $0 | 303,052 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 329,507 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-08-28 | 2025-08-29 | 207,000 | $0.01 | $2.1K | 986,352 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 290,707 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 19,390 | — | $0 | 249,156 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 1,074,696 | — | $0 | 1,074,696 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 1,612,032 | — | $0 | 1,612,032 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-17 | 2025-01-17 | 5,584 | $0.58 | $3.2K | 7,510 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-15 | 2025-01-15 | 9,803 | $0.57 | $5.6K | 13,756 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-13 | 2025-01-15 | 4,268 | $0.59 | $2.5K | 5,845 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-13 | 2025-01-15 | 5,471 | $0.59 | $3.2K | 7,623 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2024-06-14 | 2024-06-17 | 11,023 | — | $0 | 229,766 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-17 | 2024-01-17 | 5,309 | $0.67 | $3.6K | 7,785 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-17 | 2024-01-17 | 13,599 | $0.67 | $9.1K | 20,201 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-16 | 2024-01-17 | 4,681 | $0.79 | $3.7K | 7,023 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 2,544,432 | — | $0 | 2,544,432 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 565,416 | — | $0 | 565,416 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-12 | 2024-01-12 | 5,220 | $0.85 | $4.4K | 7,874 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-01-11 | 2024-01-12 | 4,009 | $0.84 | $3.4K | 6,104 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2023-06-15 | 2023-06-16 | 49,237 | — | $0 | 49,237 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2023-06-15 | 2023-06-16 | 16,581 | — | $0 | 218,743 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 202,800 | — | $0 | 202,800 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 314,256 | — | $0 | 314,256 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 1,407,072 | — | $0 | 1,407,072 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-17 | 2023-01-17 | 4,440 | $1.86 | $8.3K | 7,264 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-12 | 2023-01-12 | 4,973 | $1.71 | $8.5K | 8,121 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-11 | 2023-01-12 | 3,843 | $1.75 | $6.7K | 6,270 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-04 | 2023-01-04 | 3,584 | $1.69 | $6.1K | 5,781 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2022-06-15 | 2022-06-17 | 118,613 | — | $0 | 202,162 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-18 | 2022-01-18 | 4,368 | $3.19 | $13.9K | 7,336 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-12 | 2022-01-13 | 314,256 | — | $0 | 314,256 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-12 | 2022-01-13 | 1,407,072 | — | $0 | 1,407,072 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-12 | 2022-01-13 | 2,248 | $3.54 | $8.0K | 3,754 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-11 | 2022-01-13 | 3,770 | $3.56 | $13.4K | 6,343 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-01-04 | 2022-01-05 | 3,490 | $4.06 | $14.2K | 5,873 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-07-02 | 2021-07-02 | 4,375 | $4.26 | $18.6K | 7,329 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2021-06-16 | 2021-06-21 | 32,765 | — | $0 | 32,765 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2021-06-16 | 2021-06-21 | 8,891 | — | $0 | 83,549 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-12 | 2021-01-12 | 2,234 | $6.15 | $13.7K | 3,768 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-01-11 | 2021-01-11 | 1,086,816 | — | $0 | 1,086,816 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-01-11 | 2021-01-11 | 242,712 | — | $0 | 242,712 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2021-01-04 | 2021-01-05 | 3,499 | $5.33 | $18.6K | 5,864 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2020-12-14 | 2020-12-15 | 15,000 | $7.08 | $106.2K | 74,658 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2020-12-14 | 2020-12-15 | 207,000 | $0.69 | $142.8K | 284,808 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2020-06-09 | 2020-06-11 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2020-06-09 | 2020-06-11 | 7,523 | — | $0 | 59,658 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-01-16 | 2020-01-17 | 1,257,744 | — | $0 | 1,257,744 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-01-16 | 2020-01-17 | 280,896 | — | $0 | 280,896 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-01-14 | 2020-01-15 | 2,397 | $5.13 | $12.3K | 3,605 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2020-01-06 | 2020-01-07 | 3,731 | $1.20 | $4.5K | 5,632 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2019-06-13 | 2019-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-06-13 | 2019-06-17 | 18,248 | — | $0 | 52,135 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2019-01-14 | 2019-01-16 | 2,271 | $5.37 | $12.2K | 3,731 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-01-04 | 2019-01-08 | 1,006,224 | — | $0 | 1,006,224 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-01-04 | 2019-01-08 | 224,724 | — | $0 | 224,724 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2018-06-13 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-06-13 | 2018-06-15 | 12,406 | — | $0 | 33,887 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-01-12 | 2018-01-17 | 144,048 | — | $0 | 144,048 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-01-12 | 2018-01-17 | 644,976 | — | $0 | 644,976 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2017-06-07 | 2017-06-09 | 11,627 | — | $0 | 21,481 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2016-06-02 | 2016-06-06 | 4,854 | — | $0 | 9,854 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2015-12-17 | 2015-12-21 | 5,000 | $20.00 | $100.0K | 5,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2015-10-26 | 2015-10-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-10-19 | 2015-10-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | D To issuer | 2015-04-01 | 2015-04-03 | 28,289 | $173.00 | $4.89M | 0 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | U Tender | 2015-04-01 | 2015-04-03 | 2,969 | $173.00 | $513.6K | 0 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | A Award | 2015-01-31 | 2015-02-03 | 2,851 | — | $0 | 31,258 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | A Award | 2013-07-24 | 2013-07-26 | 14,428 | — | $0 | 14,428 | SEC↗ |